BK polyomavirus (BKPyV) remains a significant challenge after kidney transplantation.
International experts reviewed current evidence and updated recommendations according …

BK polyomavirus nephropathy (BKVN) and allograft rejection are two closely-associated
diseases on opposite ends of the immune scale in kidney transplant recipients. The principle …

The present AST‐IDCOP guidelines update information on BK polyomavirus (BKP yV)
infection, replication, and disease, which impact kidney transplantation (KT), but rarely non …

Background Urine CXCL10 is a promising noninvasive biomarker for detection of renal
allograft rejection. The aim of this study was to investigate the clinical utility of renal allograft …

Abstract Systematic screening for BKPyV-DNAemia has been advocated to aid prevention
and treatment of polyomavirus associated nephropathy (PyVAN), an important cause of …

Background Following kidney transplantation, BK virus associated nephropathy (BKVN)
occurs in 1 to 10% of kidney transplant recipients (KTR) and represents a major cause of …

BK polyomavirus-specific antibody and T-cell responses in ki... : Current Opinion in Infectious
Diseases BK polyomavirus-specific antibody and T-cell responses in kidney transplantation …

BK virus (BKV) replication occurs frequently in kidney transplant recipients (KTR), potentially
leading to BKV‐associated nephropathy (BKVAN) and graft loss. Patients with high titers of …

Background. Urine CXCL10 is a biomarker for renal allograft inflammation induced by
rejection, urinary tract infection, or BK polyomavirus (BKPyV) replication. This study aimed to …

Introduction BK polyomavirus-associated nephropathy (BKPyVAN) is associated with graft
dysfunction and loss; however, knowledge of immunosuppression reduction strategies and …